Multiple Sclerosis Trial, Not Yet Recruiting NCT07710742 Sponsor: Uludag University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT07710742
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 45 years old.
  • People who have been formally diagnosed with Multiple Sclerosis (MS) according to the 2024 McDonald criteria, which is a standard set of diagnostic guidelines used by doctors.
  • People who have not had an MS relapse (a flare-up of symptoms) in the past 3 months.
  • People with an EDSS score of 6.00 or below — this is a scale doctors use to measure MS-related disability (confirm with trial site).
  • People who have nerve pain in their legs or feet that has lasted for at least 3 months or keeps coming back.
  • People whose nerve pain has been confirmed by a neurologist (a specialist doctor for the brain and nervous system).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have another bone, joint, or nervous system condition that could interfere with taking part in the study.
  • People who have a level of muscle stiffness in the legs rated at 1+ or higher on a scale called the Modified Ashworth Scale, which doctors use to measure muscle tightness (confirm with trial site).
  • People who have difficulties with hearing, vision, or thinking/memory that could interfere with the study assessments.
  • People who are receiving any treatment beyond their usual MS medication.
  • People who are already taking part in another physical therapy program during the study period.
  • People who have pain caused by conditions that are not related to MS.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90(224)2955364

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Uludag University
Registry
ClinicalTrials.gov
Start date
9 July 2026
Est. completion
9 July 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Assessment of Neuropathic Pain; Assessment of Neuropathic Pain; Reaction Time Assesments; Balance Assessment; Joint Position Sense

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov